Nutex Health (NASDAQ:NUTX) Stock Price Down 4.4% – Here’s Why

Nutex Health Inc. (NASDAQ:NUTX) dropped 4.4% on Tuesday . The company traded as low as $160.08 and last traded at $160.63. Approximately 16,904 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 69,988 shares. The stock had previously closed at $167.96.

Analyst Upgrades and Downgrades

NUTX has been the subject of a number of recent analyst reports. Wall Street Zen lowered shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Thursday, May 22nd. Benchmark lifted their price objective on Nutex Health from $150.00 to $300.00 and gave the stock a “buy” rating in a report on Thursday, May 15th. Finally, Maxim Group upped their target price on shares of Nutex Health from $100.00 to $225.00 and gave the stock a “buy” rating in a report on Tuesday, May 20th.

Nutex Health Trading Down 6.5%

The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77. The stock’s fifty day moving average is $126.56 and its 200 day moving average is $72.33. The stock has a market cap of $873.86 million, a P/E ratio of -16.73 and a beta of -0.10.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $2.71. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The company had revenue of $211.79 million for the quarter, compared to analyst estimates of $81.09 million.

Insider Activity

In other Nutex Health news, CFO Jon Christian Bates acquired 1,000 shares of the company’s stock in a transaction dated Tuesday, April 8th. The shares were purchased at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the purchase, the chief financial officer now owns 4,888 shares in the company, valued at approximately $399,887.28. This trade represents a 25.72% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 38.52% of the company’s stock.

Hedge Funds Weigh In On Nutex Health

Hedge funds and other institutional investors have recently modified their holdings of the business. Bank of America Corp DE boosted its stake in shares of Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after purchasing an additional 2,043 shares in the last quarter. Northern Trust Corp acquired a new stake in Nutex Health in the fourth quarter valued at approximately $200,000. Millennium Management LLC acquired a new stake in Nutex Health in the fourth quarter valued at approximately $213,000. World Investment Advisors acquired a new stake in shares of Nutex Health during the fourth quarter worth $217,000. Finally, OMERS ADMINISTRATION Corp purchased a new position in shares of Nutex Health during the fourth quarter worth $231,000. 5.32% of the stock is currently owned by institutional investors.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.